Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
XORTX Therapeutics Inc
V.XRTX
Alternate Symbol(s):
XRTX
Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance...
its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:XRTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 06, 2022 7:00am
New Press Release - XORTX Welcomes New Member to the Board of Directors and Appoints Chair
CALGARY, Alberta, June 06, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to welcome...
read article.
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on Jun 01, 2022 10:58am
Ceo must be fired
In my vie he is not good for shareholders
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(10)
•••
ACTIONK
X
View Profile
View Bullboard History
Comment by
ACTIONK
on May 30, 2022 10:16pm
RE:Hello again, no value stock
You are an idiot!
(10)
•••
ACTIONK
X
View Profile
View Bullboard History
Comment by
ACTIONK
on May 30, 2022 10:15pm
RE:Spacelab…….. come back to us!
NOPE
(1)
•••
Anklebiter42
X
View Profile
View Bullboard History
Post by
Anklebiter42
on May 29, 2022 9:09pm
Spacelab…….. come back to us!
Anyone else miss Spacelab?
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on May 27, 2022 9:16am
Hello again, no value stock
Move away , this stock dropped and will drop , in my view Management very incompetent
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on May 25, 2022 8:00am
New Press Release - XORTX to Present at H. C. Wainwright Global Investment Conference 2022
CALGARY, Alberta, May 25, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a clinical stage pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its...
read article.
(1)
•••
Anklebiter42
X
View Profile
View Bullboard History
Comment by
Anklebiter42
on May 20, 2022 9:50pm
RE:Financing coming
Xortx has $15,500,000 as of March 31st. Use your head Iscfa.
(2182)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 19, 2022 9:56pm
Financing coming
May 19, 2022 To: Alberta Securities Commission, as principal regulator British Columbia Securities Commission Ontario Securities Commission XORTX Therapeutics Inc. (the "
...more
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on May 18, 2022 11:57am
Xrtx without Venture Liquidity Providers (“VLP),
Without good market making company xrtx is going nowhere.Venture Liquidity Providers (“VLP) Located in Toronto , You Ceo do something or you get nowhere
(379)
•••
vitalina2233
X
View Profile
View Bullboard History
Comment by
vitalina2233
on May 06, 2022 7:56pm
RE:Burning cash is the problem
Instead of trying to save us with your inciteful posts i think it would be better if you GFYS. Papi
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Post by
moneywinner1
on May 06, 2022 11:11am
Burning cash is the problem
Cash runs out and dilution comes to hunt you down
(264)
•••
moneywinner1
X
View Profile
View Bullboard History
Comment by
moneywinner1
on May 05, 2022 11:19am
RE:RE:RE:RE:RE:RE:Dont get SUCKED in by XORTEX CROOKS!!!
Move on
(1)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on May 05, 2022 10:48am
XORTX Opens an IND for XRx-008 Program for Autosomal
CALGARY, Alberta, May 05, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a clinical stage pharmaceutical company
...more
(6)
•••
Moonrunner
X
View Profile
View Bullboard History
Post by
Moonrunner
on May 03, 2022 3:40pm
Stock price
Spacelabs what's going on here?, What do you make of this?.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >